Ilad Alavi Darazam

Citeras av

	Alla	Sedan 2019
Citat	7575	7026
h-index	24	21
i10-index	37	33

2300

1150

575

1725

20132014201520162017201820192020202120222023202456 77 83 81 107 107 118 359 2188 2206 1644 451

Offentlig åtkomst

Visa alla

10 artiklar

1 artikel

tillgänglig

inte tillgänglig

Enligt krav från finansiärer

Medförfattare

Shervin ShokouhiDepartment of Infectious Disease, Loghman Hakim Hospital, Shahid Beheshti University of MedicalVerifierad e-postadress på sbmu.ac.ir
Latif GachkarProfessor of infectious Diseases, Shahid Beheshti university of Medical ScinceVerifierad e-postadress på sbmu.ac.ir
Davood MansouriLTRC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IranVerifierad e-postadress på sbmu.ac.ir
P.TabarsiCTERC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IranVerifierad e-postadress på sbmu.ac.ir
Mohammad M SajadiInstitute of Human Virology at the University of Maryland School of MedicineVerifierad e-postadress på ihv.umaryland.edu
Ali GhafariTehran University of medical sciencesVerifierad e-postadress på jnrt.org
Nahal MansouriPulmonary and Critical Care, Brigham and Women's HospitalVerifierad e-postadress på partners.org
Nariman Sepehrvand, MD, PhDClinical Researcher, Canadian VIGOUR Centre, University of AlbertaVerifierad e-postadress på ualberta.ca
Masoud ShamaeiClinical Tuberculosis and Epidemiology Research Center, National Research Institute of TuberculosisVerifierad e-postadress på sbmu.ac.ir
Hamidreza JamaatiCRDRC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IranVerifierad e-postadress på sbmu.ac.ir
A.A VelayatiMycobacteriology Research Center, National Research Institute of Tuberculosis and Lung DiseasesVerifierad e-postadress på theaasm.org
Majid MarjaniCTERC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IranVerifierad e-postadress på sbmu.ac.ir
Atefeh AbediniCRDRC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IranVerifierad e-postadress på sbmu.ac.ir
Mohammad Reza MasjediProfessor of Pulmonary Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.Verifierad e-postadress på sbmu.ac.ir
Zohreh AminzadehProfessor of MedicineVerifierad e-postadress på sbmu.ac.ir
Shirin KarimiNRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IranVerifierad e-postadress på theaasm.org
J. HeshmatniaCRDRC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IranVerifierad e-postadress på sbmu.ac.ir
Mostafa Alavi-MoghaddamFull Professor, Medical School, Shahid Beheshti University of Medical SciencesVerifierad e-postadress på sbmu.ac.ir
mihan pourabdollahNRITLD, Shahid Beheshti University of MedicalVerifierad e-postadress på sbmu.ac.ir
M.Bakhshayesh KaramPRDRC, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, IranVerifierad e-postadress på sbmu.ac.ir

Följ

Ilad Alavi Darazam

Department of Infectious Diseases and Tropical Medicine, Shahid Beheshti University of Medical

Verifierad e-postadress på irimc.org

Assistant Professor and Clinical Fellowship in Immunodeficiency and Transplant Infectious Diseases


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020	2438	2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020	2125	2020
Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency D Bogunovic, M Byun, LA Durfee, A Abhyankar, O Sanal, D Mansouri, ... Science 337 (6102), 1684-1688, 2012	540	2012
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021	436	2021
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021	325	2021
Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species–induced meningoencephalitis, colitis, or both F Lanternier, SA Mahdaviani, E Barbati, H Chaussade, Y Koumar, R Levy, ... Journal of Allergy and Clinical Immunology 135 (6), 1558-1568. e2, 2015	190	2015
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19 L Simani, M Ramezani, IA Darazam, M Sagharichi, MA Aalipour, ... Journal of neurovirology 27 (1), 154-159, 2021	160	2021
Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial Scientific Reports 11 (8059), 2021	129	2021
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022	128	2022
A Case of Possible Atypical Demyelinating Event of the Central Nervous System Following COVID-19 A Zoghi, M Ramezani, M Roozbeh, I Alavi Darazam, MA Sahraian Multiple Sclerosis and Related Disorders, 2020	120	2020
Anxiety among front-line health-care workers supporting patients with COVID-19: A global survey Y Cag, H Erdem, A Gormez, H Ankarali, S Hargreaves, ... General hospital psychiatry 68, 90-96, 2021	110	2021
Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study M Amanat, N Rezaei, M Roozbeh, M Shojaei, A Tafakhori, A Zoghi, ... BMC neurology 21 (1), 1-12, 2021	76	2021
Occupational exposure to blood and body fluids among health care workers in teaching hospitals in Tehran, Iran S Shokuhi, L Gachkar, I Alavi-Darazam, P Yuhanaee, M Sajadi Iranian Red Crescent Medical Journal 14 (7), 402, 2012	49	2012
Nocardiosis: risk factors, clinical characteristics and outcome IA Darazam, M Shamaei, M Mobarhan, S Ghasemi, P Tabarsi, ... Iranian Red Crescent Medical Journal 15 (5), 436, 2013	44	2013
Co-administration of albumin-furosemide in patients with the nephrotic syndrome A Ghafari, A Mehdizadeh, I Alavi-Darazam, E Rahimi, C Kargar, ... Saudi Journal of Kidney Diseases and Transplantation 22 (3), 471-475, 2011	43	2011
Neutrophil to lymphocyte ratio and C-reactive protein level as a prognostic marker in mild versus severe COVID-19 patients AA Vasmehjani, R Mardani, HN Azadani, F Zali, SDM Nasab, S Sabeti, ... Gastroenterology and Hepatology from Bed to Bench 13 (04), 2020	39	2020
Umifenovir in hospitalized moderate to severe COVID-19 patients: A randomized clinical trial IA Darazam, S Shokouhi, M Mardani, MA Pourhoseingholi, MM Rabiei, ... International Immunopharmacology 99, 107969, 2021	35	2021
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 D Matuozzo, E Talouarn, A Marchal, P Zhang, J Manry, Y Seeleuthner, ... Genome medicine 15 (1), 22, 2023	34	2023
Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency TM Campbell, Z Liu, Q Zhang, M Moncada-Velez, LE Covill, P Zhang, ... Journal of Experimental Medicine 219 (7), e20220202, 2022	32	2022
Pattern recognitions receptors in immunodeficiency disorders E Mortaza, IM Adcock, P Tabarsi, I Alavi Darazam, M Movassaghi, ... European Journal of Pharmacology, 2017	31	2017

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Följ

Citeras av

Medförfattare